CHACO Study: Control of Arterial Hypertension in Colombian Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-27

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HIGH Altitude CArdiovascular REsearch Latin America Population Study

NCT04751292

Hypertension Cardiovascular Risk Factor Altitude Hypoxia +3 more

COMPLETED

Resistant Arterial Hypertension Cohort Study

NCT01083017

Hypertension Essential Hypertension Resistant Hypertension

COMPLETED

HIGH Altitude CArdiovascular REsearch in the ANDES

NCT01830530

Hypertension High Altitude

COMPLETED PHASE4

Egypt Hypertension Study

NCT02604771

Different Classes of the Antihypertensive Treatment

COMPLETED

The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

NCT01295021

Essential Hypertension

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVE: To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

MATERIALS AND METHODS: Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in "mono-tablet" versus "multi-tablet". The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Prior diagnosis of Arterial Hypertension (AH) ≥ 3 months before
* Patients who are under pharmacological treatment of AH ≥ 3 months before

Exclusion Criteria

* The patient has rejected the participation in the study.
* Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer the questions.
* Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No